Lack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: A meta-analysis

Gene

Volumn 501, Issue 2, 2012, Pages 213-218

  Zhu, Lanfang ^a   Li, Xi ^a   Miao, Changhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Meta analysis; Polymorphism; Sepsis; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ARTICLE; CAUCASIAN; ETHNICITY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEPSIS; SIGNAL TRANSDUCTION;

EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 84860778753     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.04.027     Document Type: Article

References (41)

1. Agnese D.M., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 2002, 186:1522-1525.
2. Ahmad-Nejad P., et al. The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis. Genet. Test. Mol. Biomarkers 2011, 15:645-651.
3. Ahrens P., et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr. Res. 2004, 55:652-656.
4. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
5. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
6. Arbour N.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
7. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., Purdue G.F., Hunt J.L., Horton J.W. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J. Med. Genet. 2004, 41:808-813.
8. Barber R.C., et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 2006, 4:250-255.
9. Bochud P.Y., Bochud M., Telenti A., Calandra T. Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect. Dis. 2007, 7:531-542.
10. Bochud P.Y., et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 2008, 359:1766-1777.
11. Calvano J.E., et al. Response to systemic endotoxemia among humans bearing polymorphisms of the Toll-like receptor 4 (hTLR4). Clin. Immunol. 2006, 121:186-190.
12. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003, 197:403-411.
13. Carregaro F., Carta A., Cordeiro J.A., Lobo S.M., Silva E.H., Leopoldino A.M. Polymorphisms IL10-819 and TLR-2 are potentially associated with sepsis in Brazilian patients. Mem. Inst. Oswaldo Cruz 2010, 105:649-656.
14. Cheng B., et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit. Care Med. 2007, 35:2538-2546.
15. Creagh E.M., O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006, 27:352-357.
16. Duan Z.X., et al. Clinical relevance of the TLR4 11367 polymorphism in patients with major trauma. Arch. Surg. 2009, 144:1144-1148.
17. Everett B., et al. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun. 2007, 8:699-702.
18. Ferwerda B., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16645-16650.
19. Feterowski C., et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003, 109:426-431.
20. Guarner-Argente C., et al. Toll-like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients. Aliment. Pharmacol. Ther. 2010, 31:1192-1199.
21. Henckaerts L., et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit. Care Med. 2009, 37:192-201. e1-3.
22. Horcajada J.P., et al. Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control study. Curr. HIV Res. 2009, 7:218-223.
23. Huebinger R.M., Garner H.R., Barber R.C. Pathway genetic load allows simultaneous evaluation of multiple genetic associations. Burns 2010, 36:787-792.
24. Kajikawa O., et al. Gene expression of Toll-like receptor-2, Toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia. Gene 2005, 344:193-202.
25. Kleinnijenhuis J., Oosting M., Joosten L.A., Netea M.G., Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011, 2011:405310.
26. Kumpf O., et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit. Care 2010, 14:R103.
27. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 2002, 162:1028-1032.
28. Maratheftis C.I., Giannouli S., Spachidou M.P., Panayotou G., Voulgarelis M. RNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-II. Neoplasia 2007, 9:1012-1020.
29. Marcos M., Gomez-Munuera M., Pastor I., Gonzalez-Sarmiento R., Laso F.J. Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am. J. Epidemiol. 2009, 170:948-956.
30. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
31. Mensah N.Y., Peterlongo P., Steinherz P., Pamer E.G., Satagopan J., Papanicolaou G.A. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol. Blood Marrow Transplant. 2009, 15:1130-1133.
32. Ozgur T.T., et al. Lack of association between TLR4 polymorphism and severe gram-negative bacterial infection in neonates. Turk. J. Med. Sci. 2009, 39:423-427.
33. Poltorak A., et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 1998, 24:340-355.
34. Read R.C., et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 2001, 184:640-642.
35. Schippers E.F., et al. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 2005, 29:215-228.
36. Shalhub S., Junker C.E., Imahara S.D., Mindrinos M.N., Dissanaike S., O'Keefe G.E. Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study. J. Trauma 2009, 66:115-122. (discussion 122-3).
37. Smirnova I., et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6075-6080.
38. Tsan M.F. Heat shock proteins and high mobility group box 1 protein lack cytokine function. J. Leukoc. Biol. 2011, 89:847-853.
39. van der Graaf C., et al. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 2005, 30:264-268.
40. Van der Graaf C.A., et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw. 2006, 17:29-34.
41. Yuan F.F., et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol. 2008, 86:268-270.